 |
|
| Lamivudine(150 mg)+Zidovudine(300 mg)+Nevirapine(200 mg) | |||||||||||||||
|
Zidovudine and Lamivudine act by terminating the growth of the DNA chain and inhibiting the reverse transcriptase of HIV, where as Nevirapine is a non-nucleoside reverse transcriptase inhibtor.
Lami-Zido-Nevi Each film coated tablet contains :
Lamivudine 150mg
Zidovudine 300mg
Nevirapine 200mg
This medicine is not intended for use in paediatric patients.
This combination is indicated for treatment of HIV infection,once patients have been stabilised on the maintainence regimen of NEVIRAPINE 200mg bd, and have demonstrated adequate tolerability to the same. 1 tablet twice daily is the usual dosage for this combination, contact your health care professional for more information.
This medication should not be adminstered to patients who have just initiated therapy with Nevirapine. An initial lead in dosing of 200mg of Nevirapine once daily for 2 weeks is recommended and also to observe if the patient is reporting any adverse reactions to the same such as rashes, liver abnormalities.
